Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for SPYRE THERAPEUTICS INC, €3.5M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Cameron Turtle: trading record in brief
All filings by Cameron Turtle on record concern Spyre Therapeutics, Inc. In total, 2 filings cover trades dated from 1 July 2026 to 1 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 1 October 2026 with a transaction (€3.5M) in Spyre Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cameron Turtle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
45,000 shares@ US$89.03CommonSEC144:0001950047-26-009978
45,000 shares@ US$88.780.054% mcap100.0% of flowCommonSEC144:0001950047-26-006779
2 of 2 declarations
